Publicaties

Impact of High Altitude Therapy on Type-2 Immune Responses in Asthma Patients.
Boonpiyathad T, Capova G, Duchna HW, Croxford AL, Farine H, Dreher A, Clozel M, Schreiber J, Kubena P, Lunjani N, Mirer D, Rückert B, Satitsuksanoa P, Tan G, Groenen PMA, Akdis M, Strasser DS, Renner ED, Akdis CA.
Allergy. 2019 Jul 3. doi: 10.1111/all.13967.
PMID: 31267528

Less exacerbations and sustained asthma control 12 months after high altitude climate treatment for severe asthma.
Fieten KB, Rijssenbeek-Nouwens LH, Hashimoto S, Bel EH, Weersink EJ.
Allergy. 2019 Mar;74(3):628-630
PMID: 30428132

Preditors of treatment success in children with difficult tot treat atopic dermatitis using a personalized integrative multidisciplinary (PIM) treatment programme.
Fieten KB, Schappin R, Zijlstra WT, Rijssenbeek-Nouwens L, Meijer Y, Pasmans SGMA.
J Eur Acad Dermatol Venereol. 2019 Feb;33(2):376-383
PMID: 30198582

Preditors of benefit from high-altitude climate therapy in adults with severe asthma.
Hashimoto S, Rijssenbeek-Nouwens LH, Fieten KB, Weersink EJ, Bel EH.
Neth J Med. 2018 Jul;76(5):218-225
PMID: 30019677

Effectiveness of alpine climate treatment for children with difficult tot treat atopic dermatitis: Results of a pragmatic randomized controlled trial (DAVOS trial).
Fieten KB, Schappin R, Zijlstra WT, Figee L, Beutler J, Raymakers F, van Os-Medendorp H, Stellato R, Vandewall M, Winkelhof J, Uniken Venema M, Bruijnzeel-Koomen CAFM, Rijssenbeek-Nouwens L, van der Ent CK, van Hoffen E, Meijer Y, Pasmans SGMA.
Clin Exp Allergy. 2018 Feb;48(2):186-195
PMID: 29121432

Alpine climate treatment of atopic dermatitis: a systematic review.
Fieten KB, Weststrate AC, van Zuuren EJ, Bruijnzeel-Koomen CA, Pasmans SG.
Allergy 2015; 70:12-25.

Comparing high altitude treatment with current best care in Dutch children with moderate to severe atopic dermatitis (and asthma): study protocol for a pragmatic randomized controlled trial (DAVOS trial).Fieten KB, Zijlstra WT, van Os-Medendorp H, Meijer Y, Uniken Venema M, Rijssenbeek-Nouwens L, l’Hoir MP, Bruijnzeel-Koomen CA, Pasmans SGMA, et al.
Trials 2014; 15:94.

Comparing high altitude treatment with current best care in Dutch children with moderate to severe atopic dermatitis (and asthma): study protocol for a pragmatic randomized controlled trial (DAVOS trial).
Fieten KB, Zijlstra WT, van Os-Medendorp H, Meijer Y, Venema MU, Rijssenbeek-Nouwens L, l’Hoir MP, Bruijnzeel-Koomen CA, Pasmans SG.
Trials 2014 Mar 26;15:94.
PMID: 24670079

Health status measurement in patients with severe asthma.
Peters JB, Rijssenbeek-Nouwens LH, Bron AO, Fieten KB, Weersink EJ, Bel EH, Vercoulen JH.
Respir Med 2014;108:278-86.
PMID: 24361162

Risk of deep vein thrombosis and pulmonary embolism in asthma.
Majoor CJ, Kamphuisen PW, Zwinderman AH, Ten Brinke A, Amelink M, Rijssenbeek-Nouwens LH, Sterk PJ, Büller HR, Bel EH.
Eur Respir J. 2013 Sep;42(3):655-61
PMID: 23258790

High-altitude treatment in atopic and nonatopic patients with severe asthma.
Rijssenbeek-Nouwens LH, Fieten KB, Bron AO, Hashimoto S, Bel EH, Weersink EJ.
Eur Respir J 2012; 40:1374-80.
PMID: 22441741

High-altitude treatment: a therapeutic option for patients with severe, refractory asthma?
Rijssenbeek-Nouwens LH, Bel EH.
Clin Exp Allergy 2011; 41:775-82.
PMID: 21518039

Patients With Aspergillus Fumigatus-Associated Asthma Show Clinical Improvement At High Altitude.
Rijssenbeek-Nouwens LH, Fieten KB, Bron AO, Hashimoto S, Bel EH.
Am J Respir Crit Care Med 2011; 183, A1277.

Clinical improvement in patients with severe asthma at high altitude occurs irrespective of allergy to house dust mite.
Rijssenbeek-Nouwens LH, Fieten KB, Bron AO, Weersink EJ, Sterk PJ, Bel EH.
Am J Respir Crit Care Med 2010; 181, A5416.

Improvement in asthma control and decrease in FENO, whilst tapering the dose of oral corticosteroids during rehabilitation at high altitude in adults with severe asthma
Rijssenbeek-Nouwens LH, Fieten KB, Bron AO, Hashimoto S, Sterk PJ, Bel EH.
Am J Respir Crit Care Med 2009; 179, A2898.

How persistent is “persistent airflow limitation” in severe asthma.
Rijssenbeek-Nouwens LH, Bron AO, Naves C, Weller F, Weersink EJ, Bel EH.
Eur Respir J 2006; 28 (Suppl. 50).

Anti-allergic mattress covers in asthma: to do or not to do?
Rijssenbeek-Nouwens LH, Oosting AJ, Bruijnzeel-Koomen CA, de Bruin-Weller MS.
Clin Exp Allergy. 2003; 33:1613-7.
PMID: 14656344

Clinical evaluation of the effect of anti-allergic mattress covers in patients with moderate to severe asthma and house dust mite allergy: a randomised double blind placebo controlled study.
Rijssenbeek-Nouwens LH, Oosting AJ, de Bruin-Weller MS, Bregman I, de Monchy JG, Postma DS.
Thorax. 2002; 57:784-90.
PMID: 12200523

Assessing inpatient pulmonary rehabilitation using the patient’s view of outcome.
van Stel HF, Colland VT, Heins NL, Rijssenbeek-Nouwens LH, Everaerd W.
J Cardiopulm Rehabil. 2002; 22:201-10.
PMID: 12042690

The effect of anti-allergic mattress encasings on house dust mite-induced early- and late-airway reactions in asthmatic patients. A double-blind, placebo-controlled study.
Rijssenbeek-Nouwens LH, Oosting AJ, De Monchy JG, Bregman I, Postma DS, De Bruin-Weller MS.
Clin Exp Allergy. 2002; 32:117-25.
PMID: 12002728

Multivariable assessment of the 6-min walking test in patients with chronic obstructive pulmonary disease.
van Stel HF, Bogaard JM, Rijssenbeek-Nouwens LH, Colland VT.
Am J Respir Crit Care Med. 2001; 163:1567-71.
PMID: 11401875

Characteristics and diagnostic significance of spontaneous wheezing in children with asthma: results of continuous in vivo sound recording.
Rietveld S, Oud M, Rijssenbeek-Nouwens LH, Vaghi D, Dooijes EH.
J Asthma. 1999 Jun;36(4):351-8
PMID: 10386499

Cough as the ambiguous indicator of airway obstrutction in asthma.
Rietveld S, Rijssenbeek-Nouwens LH, Prins PJ.
J Asthma. 1999;36(2):177-86
PMID: 10227269

Diagnostics of spontaneous cough in childhood asthma: results of continuous tracheal sound recording in the homes of children.
Rietveld S, Rijssenbeek-Nouwens LH
Chest. 1998 Jan;113(1):50-4
PMID: 9440567

Allergen-induced changes in airway responsiveness are related to baseline airway responsiveness.
de Bruin-Weller MS, Weller FR, Rijssenbeek-Nouwens LH, Jansen HM, de Monchy JG.
Allergy. 1996; 51:401-6.
PMID: 8837663

Characteristics of wheeze during histamine-induced airways obstruction in children with asthma.
Rietveld S, Dooijes EH, Rijssenbeek-Nouwens LH, Smit F, Prins PJ, Kolk AM, Everaerd WA.
Thorax. 1995 Feb;50(2):143-8
PMID: 7701452

Lack of effect of cetirizine on early and late asthmatic response after allergen challenge.
De Bruin-Weller MS, Rijssenbeek-Nouwens LH, de Monchy JG.
J Allergy Clin Immunol. 1994 Aug;94(2 Pt 1):231-9
PMID: 8064075

Parental treatment management skills in pediatric atopic dermatitis.
Fieten KB, Bruins FM, Zijlstra WT, Schappin R, Figee L, de Bruijn M, Russel IMB, van Os- Medendorp H, Pasmans SGMA. Clinical and experimental dermatology in press.

Effectiveness of alpine climate treatment for children with difficult to treat atopic dermatitis: results of a pragmatic randomized controlled trial (DAVOS trial). Fieten KB, Schappin R, Zijlstra WT, Figee L, Beutler J, Raymakers F, van Os-Medendorp H, Stellato R, Vandewall M, Winkelhof J, Uniken Venema M, Bruijnzeel-Koomen C, Rijssenbeek- Nouwens L, van der Ent CK, van Hoffen E, Meijer Y, Pasmans SGMA. Clinical and Experimental Allergy, in press.

Interned-based self-management support after pulmonary rehabilitation of patients with severe asthma: a randomised controlled trial
Thijs Beerthuizen MD1, Lucia  Rijssenbeek-Nouwens MD PhD2, Jiska B. Snoeck-Stroband MD PhD1, Jacob K. Sont PhD1, submitted. European Respiratory Journal

Heeft u een vraag ? Wij staan u graag te woord.

+31 6 31 00 29 05
Stuur een e-mail